Aaron R. Thorner - Concepedia

Author

Aaron R. Thorner

Also Known As

A R Thorner, A Thörner, A. Thorner, A.R. Thorner, AARON R. THORNER, Aaron R. Thorner, Aaron R Thorner, Aaron R. Thorner, Aaron Thorner, Aaron R. Thorner

278

Publications

12.6K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Broad Institute Brigham and Women's Hospital Harvard University Massachusetts General Hospital

About

Aaron R. Thorner is an author at Dana-Farber Cancer Institute specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	5.3K
2	Health Sciences	4	4	1.1K
3	Engineering	2	2	521
4	Public Health	1	1	47
5	Blood Transplantation	1	1	68

Aaron R. Thorner

Publications

12.2K

Citations

H-Index

Page 1

	Year	Citations
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes Bjoern Chapuy, Chip Stewart, Andrew Dunford, Nature Medicine Hematological MalignancyLymphoid NeoplasiaMolecular SubtypesImmunologyPathology	2018	1.9K
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets Priscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Cancer Discovery	2015	1.1K
Genetic and transcriptional evolution alters cancer cell line drug response Uri Ben‐David, Benjamin A. Siranosian, Gavin Ha, Nature Tumor HeterogeneityMedicineOncogenic AgentCancer GenomicsLine Drug Response	2018	890
Targetable genetic features of primary testicular and primary central nervous system lymphomas Bjoern Chapuy, Margaretha G.M. Roemer, Chip Stewart, Blood	2015	590
The Genomic Landscape of Pediatric Ewing Sarcoma Brian D. Crompton, Chip Stewart, Amaro Taylor‐Weiner, Cancer Discovery	2014	561
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas Priscilla K. Brastianos, Amaro Taylor‐Weiner, Peter Manley, Nature Genetics Somatic VariantMedicineGeneticsPathologyIdentifies Braf Mutations	2014	503
Institutional implementation of clinical tumor profiling on an unselected cancer population Lynette M. Sholl, T. Khanh, Priyanka Shivdasani, JCI Insight	2016	434
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Cancer Cell Knockout MouseXenotransplantationXenografts Enables DiscoveryEngineeringIn Vivo System	2016	302
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma Eirini Pectasides, Matthew D. Stachler, Sarah Derks, Cancer Discovery	2017	293
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing Magdalena E. Tyburczy, Kira A. Dies, Jennifer Glass, PLoS Genetics	2015	290

Page 1